What is the recommended infusion rate in mL per hour for metaraminol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metaraminol Infusion Rate

Metaraminol is typically infused at 1-6 mg/hour (approximately 15-100 mcg/min) in critically ill patients, with most patients requiring doses in the lower range of 1-2 mg/hour.

Standard Dosing Parameters

Based on the most recent clinical evidence, metaraminol infusion follows these parameters:

  • Initial rate: 1-2 mg/hour (15-30 mcg/min) 1
  • Typical range: 1-6 mg/hour (15-100 mcg/min) 1
  • Median duration: 10 hours (IQR 3-24 hours) 1

Concentration and Administration

The standard preparation uses:

  • Concentration: 0.02 mg/mL (20 mcg/mL)
  • Fixed infusion rate: 100 mL/hour 2
  • This delivers 2 mg/hour at baseline

Clinical Context and Adjustments

For Cesarean Section (Spinal Anesthesia)

The ED50 for preventing post-spinal hypotension varies by maternal BMI:

  • Standard BMI (<30 kg/m²): 1.84 mg/hour (95% CI: 1.76-1.89 mg/h) 2
  • Obese patients (BMI ≥30 kg/m²): 2.28 mg/hour (95% CI: 2.19-2.43 mg/h) 2

The obese group requires approximately 24% higher doses. Adjust the prophylactic dose upward for obese parturients to maintain adequate blood pressure control.

For ICU Patients

In the intensive care setting, dosing is generally conservative 1:

  • Most patients receive 1-2 mg/hour initially
  • Doses rarely exceed 6 mg/hour
  • Transition to norepinephrine typically occurs at median 7 hours if higher vasopressor support is needed 1

Important Clinical Considerations

Hemodynamic Stability

Metaraminol maintains stable hemodynamics without causing tachycardia 1. During infusion:

  • Heart rate remains stable
  • Mean arterial pressure is well-maintained
  • Urine output typically stays >30 mL/hour for first 24 hours
  • No clinical evidence of tachyphylaxis

Push-Dose Administration

For intubation in septic patients, prophylactic push-dose metaraminol (typically 0.5-2 mg bolus) reduces post-intubation hypotension from 49.4% to 21.1% 3. This can be combined with continuous infusion.

Transition Strategy

Clinicians frequently transition to norepinephrine early (median 7 hours) despite low metaraminol doses 1. Consider switching when:

  • Doses approach 4-6 mg/hour
  • Patient requires more aggressive vasopressor support
  • Underlying shock state worsens

Common Pitfalls

  • Underdosing in obese patients: Remember to increase initial dose by ~25% for BMI ≥30 kg/m²
  • Premature escalation: Metaraminol is effective at low doses; avoid unnecessary early transition to norepinephrine
  • Fixed dosing: Adjust based on patient weight and clinical response rather than using one-size-fits-all approach

The evidence shows metaraminol is particularly useful for less severe hypotension in ICU patients with low illness severity and for preventing spinal anesthesia-induced hypotension in obstetric patients 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.